Physician profile
Walton A Taylor
NPI 1063455533
$369,060.14
in general payments reported to CMS, 2019-2025
30 companies · $43K in 2025
The $43K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61K · 2020: $76K · 2021: $63K · 2022: $44K · 2023: $43K · 2024: $40K · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $123K · Food and Beverage: $2,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $122,500.00 |
| Food and Beverage | $2,482.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impedimed, INC. | $315,538.89 | 2019-2025 | |
| Icad, INC | $46,788.93 | 2020-2023 | Axxent Surface Controller |
| Heron Therapeutics, INC. | $1,900.00 | 2020 | |
| Leica Microsystems INC. | $1,694.12 | 2022 | |
| Endomagnetics LTD | $1,187.04 | 2019-2024 | Magseed, Magtrace |
| Myriad Genetic Laboratories, INC. | $470.55 | 2021-2024 | Myrisk |
| Stryker Corporation | $176.53 | 2023-2025 | Molli, Spy-Phi System |
| Merck Sharp & Dohme LLC | $173.12 | 2019-2025 | Keytruda, Lynparza |
| Axogen | $145.42 | 2025 | |
| Hologic Sales and Service, LLC | $143.11 | 2025 | Magseed, Magtrace |
| Tactile Systems Technology INC | $94.54 | 2022-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Becton, Dickinson and Company | $89.34 | 2025 | |
| Molli Surgical (US) INC | $80.58 | 2023 | |
| Tela Bio, INC. | $79.17 | 2024 | Ovitex 2s |
| Intuitive Surgical, INC. | $55.36 | 2019-2023 | Da Vinci Surgical System |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $48.87 | 2019 | |
| Smith+Nephew, INC. | $48.00 | 2020-2025 | Stravix |
| Ge Healthcare | $45.91 | 2022 | |
| Dilon Technologies, INC. | $45.86 | 2023 | Hemoblast Bellows |
| Kci USA, INC. | $43.20 | 2019 | |
| Hologic INC | $36.01 | 2019 | |
| Bard Peripheral Vascular, INC. | $33.30 | 2021-2023 | |
| Merit Medical Systems INC | $20.47 | 2025 | Savi Scout |
| Kerecis Limited | $19.85 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Prescient Surgical | $19.33 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $18.14 | 2025 | |
| Elucent Medical | $18.05 | 2025 | |
| Trevena, INC. | $17.85 | 2022 | |
| Medtronic, INC. | $15.14 | 2023 | Dextile |
| Ethicon US, LLC | $13.46 | 2023 | Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walton Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.